Fortress Biotech, Inc.FBIONASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank86
5Y CAGR+24.0%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+24.0%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202422.46%
202330.08%
2022-7.97%
2021-100.00%
202014.93%
20197.65%
2018-33.63%
2017-36.65%
2016-30.04%
2015-144.68%